Beacon’s AI-powered technology is using precision neuroscience to accelerate drug development and power the next generation of home sleep testing diagnostics, so life-changing treatments can reach the right patients faster.
Clinical Trials and Research
Beacon is the leading precision medicine platform for collecting, integrating and analyzing EEG data across the full drug development lifecycle, from clinical trial design to biomarker discovery.
For Providers & Patients
Home Sleep Testing
Scalable, at-home solutions for sleep physicians, neurologists and primary care. Powered by the same precision platform trusted by leading pharmaceutical companies.
Our Mission
Transforming treatment for patients, from clinical development to clinical practice
Developing Innovative Therapies
With at-home AI-driven technology, Beacon’s precision medicine platform collects, integrates, and analyzes neurophysiological and cardiopulmonary data throughout the full Phase 1-4 development lifecycle of pharmacotherapies.
Scaling At-Home Diagnostics
At-home sleep testing enables multi-night data collection in patients' natural sleep environments. This level of precision brings new insight into underlying health conditions to build the right treatment plans.
Building the Largest Neurodiagnostic Dataset
We are building the world's largest clinically validated neurophysiology dataset, generating the depth and scale of evidence needed to unlock a deeper understanding of brain health and more targeted, personalized therapies.
Delivering Value
Beacon by Numbers
News & Resources
What's New at Beacon
Check out our latest press releases, announcements, partnerships, and more.
Press Release
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
Beacon Biosignals
News
Beacon Biosignals Named in Fast Company's Most Innovative Companies of 2026!
Beacon Biosignals
Press Release
Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG
Beacon Biosignals